These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 23890063)

  • 1. Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.
    Kalos M; June CH
    Immunity; 2013 Jul; 39(1):49-60. PubMed ID: 23890063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy.
    Rath JA; Arber C
    Cells; 2020 Jun; 9(6):. PubMed ID: 32570906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making and circumventing tolerance to cancer.
    Kammertoens T; Blankenstein T
    Eur J Immunol; 2009 Sep; 39(9):2345-53. PubMed ID: 19634191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Next generation engineered T cells for cell therapy: from lymphoma to solid tumors].
    Catros V
    Med Sci (Paris); 2019 Apr; 35(4):316-326. PubMed ID: 31038109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering CAR-T Cells for Next-Generation Cancer Therapy.
    Hong M; Clubb JD; Chen YY
    Cancer Cell; 2020 Oct; 38(4):473-488. PubMed ID: 32735779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive T-cell therapy for cancer: The era of engineered T cells.
    Bonini C; Mondino A
    Eur J Immunol; 2015 Sep; 45(9):2457-69. PubMed ID: 26202766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapy with lymphocytes genetically engineered with T cell receptors for solid cancers.
    Chen L; Qiao D; Wang J; Tian G; Wang M
    Immunol Lett; 2019 Dec; 216():51-62. PubMed ID: 31597088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive immunotherapy for cancer or viruses.
    Maus MV; Fraietta JA; Levine BL; Kalos M; Zhao Y; June CH
    Annu Rev Immunol; 2014; 32():189-225. PubMed ID: 24423116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition.
    Houot R; Schultz LM; Marabelle A; Kohrt H
    Cancer Immunol Res; 2015 Oct; 3(10):1115-22. PubMed ID: 26438444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects.
    Di S; Li Z
    Sci China Life Sci; 2016 Apr; 59(4):360-9. PubMed ID: 26968709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.
    Chang ZL; Chen YY
    Trends Mol Med; 2017 May; 23(5):430-450. PubMed ID: 28416139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAR T Cell Therapy for Solid Tumors.
    Newick K; O'Brien S; Moon E; Albelda SM
    Annu Rev Med; 2017 Jan; 68():139-152. PubMed ID: 27860544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell engineering as therapy for cancer and HIV: our synthetic future.
    June CH; Levine BL
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140374. PubMed ID: 26416683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of endogenous T cells for adoptive transfer.
    Yee C
    Immunol Rev; 2014 Jan; 257(1):250-63. PubMed ID: 24329802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering T cells for adoptive therapy: outsmarting the tumor.
    Kunert A; Debets R
    Curr Opin Immunol; 2018 Apr; 51():133-139. PubMed ID: 29579622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Armed T cells with CAR for cancer immunotherapy.
    Wei YQ
    Sci China Life Sci; 2016 Apr; 59(4):331-2. PubMed ID: 27080712
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating cancer with genetically engineered T cells.
    Park TS; Rosenberg SA; Morgan RA
    Trends Biotechnol; 2011 Nov; 29(11):550-7. PubMed ID: 21663987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo gene transfer for improved adoptive immunotherapy of cancer.
    Ngo MC; Rooney CM; Howard JM; Heslop HE
    Hum Mol Genet; 2011 Apr; 20(R1):R93-9. PubMed ID: 21415041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen choice in adoptive T-cell therapy of cancer.
    Offringa R
    Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing guidelines for CAR-T cells: challenges and considerations.
    Wang W; Qin DY; Zhang BL; Wei W; Wang YS; Wei YQ
    Sci China Life Sci; 2016 Apr; 59(4):333-9. PubMed ID: 26965523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.